ENOX2 Target for the Anticancer Isoflavone ME-143
نویسندگان
چکیده
منابع مشابه
tNOX (ENOX2) Target for Chemosensitization-Low-Dose Responses in the Hormetic Concentration Range
An emerging concept of cancer chemotherapy is that of chemosensitization. Most often applied to the treatment of drug-resistance cancers, chemosensitization has utility when such cancers are rendered drug sensitive through treatment with the sensitizing agent. A particularly striking example of chemosensitization is that encountered with the synthetic isoflavene phenoxodiol where patients with ...
متن کاملTumor Vasculature: a Target for Anticancer Therapies
Historically, approaches to improve cancer therapy have focused primarily on achieving increased tumor cell kill. Recently however another treatment approach has garnered considerable attention. Rather than targeting the neoplastic cell population directly, this strategy endeavors to impair the tumor’s nutritional support system by target the tumor blood vessel network. Vascular targeting appro...
متن کاملMycotoxin- A Target for Anticancer Drug Development
The aim of this present article is to underscore the recent evidence linking anticancer activity and free radical scavenging activity of mycotoxins and its significance in the development of newer anticancer drugs. Although acute exposure to a massive amount of mycotoxin is rare but long-term exposure/consumption of food with low levels of lipophilic mycotoxin remains problematic. The aneuploid...
متن کاملApoptosis: A Target for Anticancer Therapy
Apoptosis, the cell's natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage of hundreds of proteins. In cancer, the apoptotic pathway is typically inhibited through a wide variety of means including overexpression of antiapoptotic proteins and under-expression of proapoptotic ...
متن کاملDual-Target Anticancer Drug Candidates: Rational Design and Simulation Studies
This study aims to design some dual-target anticancer candidates, capable to act as an alkylating agent as well as a thymidylate synthase (TS) inhibitor. The designed scaffold is a combination of nucleobase, amino acid and aziridine structures. The candidates are docked into TS and three DNA double strand structures and evaluated based on their binding interaction energies and ligand efficienci...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
سال: 2014
ISSN: 0965-0407
DOI: 10.3727/096504014x14077751730270